Read this manager's filing book
Disclosed positions
Nextech Invest Ltd.: source evidence dated 2025-02-15T04:59:59.999Z.
- Issuer
- REVOLUTION MEDICINES INC
- Ticker
- RVMD
- Class
- COM
- Reported value
- $332,471,545
- Reported amount
- 7,601,087
- Unit
- SH
- Option
- None
The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.
What was reported for this quarter?
13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.
SEC 13F-HR: 0001104659-25-014109Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filings
Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filingsKeep reporting dates and units beside the answer, and inspect its original citations.
Disclosed positions
See the complete disclosed positions
| REVOLUTION MEDICINES INC | RVMD | COM | $332,471,545 | 7,601,087 | SH | None |
| TYRA BIOSCIENCES INC | TYRA | COM | $56,376,468 | 4,055,861 | SH | None |
| ORIC PHARMACEUTICALS INC | ORIC | COM | $42,655,712 | 5,285,714 | SH | None |
| CARGO THERAPEUTICS INC | CRGX | COM | $38,104,879 | 2,642,502 | SH | None |
| ARVINAS INC | ARVN | COM | $26,998,913 | 1,408,394 | SH | None |
| MERSANA THERAPEUTICS INC | Unresolved | COM | $17,256,162 | 12,067,246 | SH | None |
| TANGO THERAPEUTICS INC | TNGX | COM | $17,099,998 | 5,533,980 | SH | None |
| ZYMEWORKS INC | ZYME | COM | $16,308,169 | 1,113,946 | SH | None |
| RELAY THERAPEUTICS INC | RLAY | COM | $15,847,205 | 3,846,409 | SH | None |
| CULLINAN ONCOLOGY INC | CGEM | COM | $13,899,146 | 1,141,145 | SH | None |
| ALUMIS INC | ALMS | COM | $11,609,204 | 1,476,998 | SH | None |
| ARS PHARMACEUTICALS INC | SPRY | COM | $9,882,491 | 936,729 | SH | None |
| CONTEXT THERAPEUTICS INC | CNTX | COM | $7,790,323 | 7,419,355 | SH | None |
| SILENCE THERAPEUTICS PLC | SLN | ADS | $6,552,512 | 952,400 | SH | None |
| BOUNDLESS BIO INC | BOLD | COM | $3,561,400 | 1,228,069 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 1 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.